Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Novel IRAK-4 inhibitors discovered at Beijing Hanmi Pharmaceutical

Feb. 24, 2017

Novel TNF-alpha antagonists synthesized at Bristol-Myers Squibb

Feb. 21, 2017

Merck KGaA compares MSB-11022 to Humira in phase III trial for rheumatoid arthritis

Feb. 21, 2017

Taiho Pharmaceutical discovers JAK3 inhibitors

Feb. 16, 2017

European Commission approves Olumiant for rheumatoid arthritis

Feb. 14, 2017

Can-Fite Biopharma set to begin phase III ACRobat study of piclidenoson

Feb. 9, 2017

Flexion Therapeutics' Zilretta NDA accepted for review by FDA

Feb. 8, 2017

Takeda discovers prostanoid EP4 receptor antagonists

Feb. 7, 2017

Institute of Experimental Botany identifies apoptosis inducers/ROS inhibitors

Feb. 7, 2017

Seikagaku initiates phase III study of SI-613 to treat osteoarthritis in Japan

Feb. 6, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...